Clearmind MedicineCMND
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 8 institutions reported holding Clearmind Medicine Inc. (CMND) in their 13F filings, up 4 from Q2 2024. 5 opened new positions and 1 sold out. The largest holders were Gotham Asset Management ($5.1M), AdvisorShares Investments LLC ($208K) and UBS Group AG ($172K). 2 famous investors held it, including Joel Greenblatt (0.1% of Gotham Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Clearmind Medicine Inc.
- CUSIP
- 185053402
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $5.3M |
| Exits | 1 | $28K |
All 13F filers, Q2 2024 → Q3 2024: 553,209 shares bought and 16,586 shares sold, net +536,623 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Gotham Asset Management | 0.05% | New | 339,008 | $5.1M |
| AdvisorShares Investments LLC | 0.04% | Add +32.6% | 170,641 | $208K |
| UBS Group AG | 0.00% | New | 141,337 | $172K |
| Cornerstone Wealth Group, LLC | 0.00% | No change | 20,000 | $24K |
| Citadel Advisors | 0.00% | New | 17,729 | $22K |
| HRT Financial LP | 0.00% | New | 12,756 | $15K |
| Royal Bank of Canada | 0.00% | No change | 569 | $1K |
| National Bank of Canada | 0.00% | New | 379 | $462 |
"% of holder's portfolio" is CMND's weight in each manager's 13F, not the share of Clearmind Medicine Inc. the manager owns.